Titre : Fumonisines

Fumonisines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Fumonisines : Questions médicales les plus fréquentes", "headline": "Fumonisines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Fumonisines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-17", "dateModified": "2025-05-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Fumonisines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mycotoxines", "url": "https://questionsmedicales.fr/mesh/D009183", "about": { "@type": "MedicalCondition", "name": "Mycotoxines", "code": { "@type": "MedicalCode", "code": "D009183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.587" } } }, "about": { "@type": "MedicalCondition", "name": "Fumonisines", "alternateName": "Fumonisins", "code": { "@type": "MedicalCode", "code": "D037341", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "András Szabó", "url": "https://questionsmedicales.fr/author/Andr%C3%A1s%20Szab%C3%B3", "affiliation": { "@type": "Organization", "name": "MTA-KE-SZIE Mycotoxins in the Food Chain Research Group, Kaposvár University, Kaposvár, Hungary." } }, { "@type": "Person", "name": "Melinda Kovács", "url": "https://questionsmedicales.fr/author/Melinda%20Kov%C3%A1cs", "affiliation": { "@type": "Organization", "name": "MTA-KE-SZIE Mycotoxins in the Food Chain Research Group, Kaposvár University, Kaposvár, Hungary." } }, { "@type": "Person", "name": "Naeem Sheik Abdul", "url": "https://questionsmedicales.fr/author/Naeem%20Sheik%20Abdul", "affiliation": { "@type": "Organization", "name": "Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa; Applied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Cape Town, 7535, South Africa." } }, { "@type": "Person", "name": "Anil A Chuturgoon", "url": "https://questionsmedicales.fr/author/Anil%20A%20Chuturgoon", "affiliation": { "@type": "Organization", "name": "Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa. Electronic address: chutur@ukzn.ac.za." } }, { "@type": "Person", "name": "Terisha Ghazi", "url": "https://questionsmedicales.fr/author/Terisha%20Ghazi", "affiliation": { "@type": "Organization", "name": "Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4041, South Africa." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36097245", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.17269/s41997-022-00691-z" } }, { "@type": "ScholarlyArticle", "name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37047951", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20075336" } }, { "@type": "ScholarlyArticle", "name": "Global pen pal education intervention among student pharmacists: A pilot project.", "datePublished": "2022-09-22", "url": "https://questionsmedicales.fr/article/36153244", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cptl.2022.09.020" } }, { "@type": "ScholarlyArticle", "name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39457265", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph21101292" } }, { "@type": "ScholarlyArticle", "name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.", "datePublished": "2023-02-16", "url": "https://questionsmedicales.fr/article/36798046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348231157833" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Toxines biologiques", "item": "https://questionsmedicales.fr/mesh/D014118" }, { "@type": "ListItem", "position": 4, "name": "Mycotoxines", "item": "https://questionsmedicales.fr/mesh/D009183" }, { "@type": "ListItem", "position": 5, "name": "Fumonisines", "item": "https://questionsmedicales.fr/mesh/D037341" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Fumonisines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Fumonisines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Fumonisines", "description": "Comment diagnostiquer une intoxication par fumonisines ?\nQuels tests sont utilisés pour détecter les fumonisines ?\nQuels symptômes indiquent une intoxication par fumonisines ?\nPeut-on détecter les fumonisines dans le sang ?\nLes tests de laboratoire sont-ils fiables pour les fumonisines ?", "url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=Pilot+Projects&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Fumonisines", "description": "Quels sont les symptômes d'une exposition aiguë aux fumonisines ?\nLes fumonisines causent-elles des effets neurologiques ?\nY a-t-il des symptômes à long terme liés aux fumonisines ?\nLes symptômes varient-ils selon l'âge ?\nLes symptômes sont-ils immédiats après exposition ?", "url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=Pilot+Projects&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Fumonisines", "description": "Comment prévenir l'exposition aux fumonisines ?\nLes contrôles alimentaires sont-ils efficaces contre les fumonisines ?\nQuelles pratiques agricoles aident à prévenir les fumonisines ?\nLes fumonisines peuvent-elles être éliminées par la cuisson ?\nLes tests de détection sont-ils recommandés pour les aliments ?", "url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=Pilot+Projects&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Fumonisines", "description": "Quel traitement est recommandé pour l'intoxication par fumonisines ?\nDes antidotes existent-ils pour les fumonisines ?\nComment gérer les symptômes gastro-intestinaux ?\nLes traitements varient-ils selon la gravité de l'intoxication ?\nFaut-il hospitaliser les patients exposés aux fumonisines ?", "url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=Pilot+Projects&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Fumonisines", "description": "Quelles sont les complications possibles d'une intoxication par fumonisines ?\nLes fumonisines peuvent-elles affecter le foie ?\nY a-t-il un risque accru de cancer avec les fumonisines ?\nLes fumonisines peuvent-elles causer des problèmes respiratoires ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=Pilot+Projects&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Fumonisines", "description": "Quels sont les principaux facteurs de risque d'exposition aux fumonisines ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLe climat influence-t-il la présence de fumonisines ?\nLes enfants sont-ils plus à risque d'intoxication ?\nLes travailleurs agricoles sont-ils exposés aux fumonisines ?", "url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication par fumonisines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'analyse des échantillons alimentaires et des tests biologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les fumonisines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests chromatographiques comme la HPLC sont couramment utilisés pour détecter les fumonisines." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication par fumonisines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des nausées et des troubles neurologiques." } }, { "@type": "Question", "name": "Peut-on détecter les fumonisines dans le sang ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des analyses sanguines peuvent révéler la présence de fumonisines dans l'organisme." } }, { "@type": "Question", "name": "Les tests de laboratoire sont-ils fiables pour les fumonisines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests de laboratoire sont généralement fiables pour détecter les fumonisines." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë aux fumonisines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des vomissements, des douleurs abdominales et des diarrhées." } }, { "@type": "Question", "name": "Les fumonisines causent-elles des effets neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition aux fumonisines peut entraîner des troubles neurologiques et cognitifs." } }, { "@type": "Question", "name": "Y a-t-il des symptômes à long terme liés aux fumonisines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut augmenter le risque de cancers et de maladies chroniques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets des fumonisines que les adultes." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats après exposition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, certains symptômes peuvent apparaître plusieurs heures après l'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux fumonisines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments contaminés et stockez les céréales dans des conditions appropriées." } }, { "@type": "Question", "name": "Les contrôles alimentaires sont-ils efficaces contre les fumonisines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers des aliments peuvent réduire le risque d'exposition." } }, { "@type": "Question", "name": "Quelles pratiques agricoles aident à prévenir les fumonisines ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La rotation des cultures et le contrôle de l'humidité peuvent aider à prévenir leur apparition." } }, { "@type": "Question", "name": "Les fumonisines peuvent-elles être éliminées par la cuisson ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "La cuisson ne détruit pas les fumonisines, il est donc crucial de prévenir leur contamination." } }, { "@type": "Question", "name": "Les tests de détection sont-ils recommandés pour les aliments ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests de détection réguliers sont recommandés pour assurer la sécurité alimentaire." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour l'intoxication par fumonisines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste principalement en des soins de soutien et une hydratation adéquate." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les fumonisines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour les intoxications par fumonisines." } }, { "@type": "Question", "name": "Comment gérer les symptômes gastro-intestinaux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antiémétiques et des solutions de réhydratation peuvent être utilisés." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la gravité de l'intoxication ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être plus intensifs en cas d'intoxication sévère." } }, { "@type": "Question", "name": "Faut-il hospitaliser les patients exposés aux fumonisines ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation peut être nécessaire pour les cas graves ou les complications." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une intoxication par fumonisines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, des cancers et des maladies chroniques." } }, { "@type": "Question", "name": "Les fumonisines peuvent-elles affecter le foie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition aux fumonisines peut entraîner des lésions hépatiques et des dysfonctionnements." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancer avec les fumonisines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent un lien entre l'exposition aux fumonisines et certains cancers." } }, { "@type": "Question", "name": "Les fumonisines peuvent-elles causer des problèmes respiratoires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que l'exposition prolongée peut entraîner des problèmes respiratoires." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition aux fumonisines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation de maïs contaminé et le stockage inadéquat." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées peuvent être plus vulnérables aux effets des fumonisines." } }, { "@type": "Question", "name": "Le climat influence-t-il la présence de fumonisines ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions climatiques humides favorisent la croissance des champignons producteurs de fumonisines." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque d'intoxication ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus sensibles aux effets toxiques des fumonisines en raison de leur métabolisme." } }, { "@type": "Question", "name": "Les travailleurs agricoles sont-ils exposés aux fumonisines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs agricoles peuvent être exposés lors de la manipulation de cultures contaminées." } } ] } ] }

Sources (10000 au total)

SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.

Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro... An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p... A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple... This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...

Global pen pal education intervention among student pharmacists: A pilot project.

Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim... This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm... In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...

Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.

In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan... Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and... The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...

Community-supported teaching on the topic of transgender identity in undergraduate medical education - a pilot project.

Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab... During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ... The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga... One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...

Assessing tenant health amid social housing redevelopment: lessons from a pilot project.

To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th... Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,... A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported.... This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...

Developing a trigger tool to monitor adverse events during haemodialysis in children: a pilot project.

We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events.... Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a... There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions... This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...

vSEMERA: pilot project assessing health profession students' experiences in an international virtual research program.

The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho... vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a... The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche... vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...